Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Public ClinicalTrials.gov record NCT04723095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04723095
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Enrollment
- 750 participants
Conditions and interventions
Conditions
- Cervical Large Cell Neuroendocrine Carcinoma
- Cervical Neuroendocrine Carcinoma
- Cervical Small Cell Carcinoma
- Cervical Undifferentiated Carcinoma
- Stage I Cervical Cancer AJCC v8
- Stage IA Cervical Cancer AJCC v8
- Stage IA1 Cervical Cancer AJCC v8
- Stage IA2 Cervical Cancer AJCC v8
- Stage IB Cervical Cancer AJCC v8
- Stage IB1 Cervical Cancer AJCC v8
- Stage IB2 Cervical Cancer AJCC v8
- Stage II Cervical Cancer AJCC v8
- Stage IIA Cervical Cancer AJCC v8
- Stage IIA1 Cervical Cancer AJCC v8
- Stage IIA2 Cervical Cancer AJCC v8
- Stage IIB Cervical Cancer AJCC v8
- Stage III Cervical Cancer AJCC v8
- Stage IIIA Cervical Cancer AJCC v8
- Stage IIIB Cervical Cancer AJCC v8
- Stage IV Cervical Cancer AJCC v8
- Stage IVA Cervical Cancer AJCC v8
- Stage IVB Cervical Cancer AJCC v8
Interventions
- Follow-Up Other
- Medical Chart Review Other
Other
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2013
- Primary completion
- Dec 31, 2043
- Completion
- Dec 31, 2043
- Last update posted
- Mar 4, 2026
2013 – 2044
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04723095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04723095 live on ClinicalTrials.gov.